NASDAQ:BTCY Biotricity (BTCY) Stock Price, News & Analysis $0.20 -0.05 (-18.52%) As of 03:56 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsEarningsHeadlinesSEC FilingsShort InterestTrendsBuy This Stock About Biotricity Stock (NASDAQ:BTCY) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Biotricity alerts:Sign Up Key Stats Today's Range$0.19▼$0.2650-Day Range$0.20▼$0.2752-Week Range$0.19▼$0.75Volume207,109 shsAverage Volume46,407 shsMarket Capitalization$5.71 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Biotricity, Inc. (NASDAQ:BTCY) is a digital health company specializing in remote patient monitoring solutions across cardiovascular and chronic disease management. The firm develops and commercializes a patented wearable biosensor platform designed to capture continuous physiological data, including electrocardiogram (ECG) readings and heart rate variability. This integrated system combines lightweight, adhesive biosensors with cloud-based analytics and clinician-facing software to support early detection of cardiac arrhythmias and facilitate telehealth care delivery. The company’s flagship offering, the Bioflux™ platform, comprises a small, single-use wearable device that transmits real-time data to a secure portal, where advanced algorithms analyze cardiac patterns and generate clinician alerts. Complementing the hardware are subscription-based services—such as Bioflux™ Rx—through which Biotricity provides end-to-end monitoring programs under a prescription model. These programs enable cardiologists, primary care physicians, and remote monitoring centers to review patient data remotely, optimize treatment plans and enhance patient engagement without the need for in-office visits. Founded in 2015 and headquartered in Menlo Park, California, Biotricity serves healthcare providers and payors throughout the United States, with emerging international partnerships aimed at expanding telemedicine adoption. Under the leadership of Founder and Chief Executive Officer Amir Kalali, the company has secured regulatory clearances for multiple product lines and continues to invest in research and development to broaden its digital health ecosystem. Biotricity’s solutions target efficient, patient-centric care by leveraging real-world data and scalable technology to address growing demands for remote monitoring in modern healthcare.AI Generated. May Contain Errors. Read More Receive BTCY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Biotricity and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. BTCY Stock News HeadlinesCritical Analysis: Interpace Biosciences (OTCMKTS:IDXG) and Biotricity (NASDAQ:BTCY)May 13 at 4:21 AM | americanbankingnews.comBiotricity Q3 2026 Earnings Call: Complete TranscriptFebruary 14, 2026 | benzinga.comIran War Update: Trump’s Hand-Written Letter Reveals What Comes NextJim Rickards has uncovered what he believes is Trump's economic plan, with a key trigger date of May 15. The Financial Times estimates this move could help unleash $100 trillion in new wealth. Billionaire investors John Paulson, Ray Dalio, and Paul Tudor Jones are already said to be preparing. The window to get ahead of this may be closing.May 14 at 1:00 AM | Paradigm Press (Ad)Biotricity, Inc. (OTC:BTCY) Q3 2026 earnings call transcriptFebruary 12, 2026 | msn.comBiotricity Inc (BTCY) Q3 2026 Earnings Call Highlights: Strong Revenue Growth and Strategic AI ...February 12, 2026 | finance.yahoo.comBiotricity, Inc. (BTCY) Q3 2026 Earnings Call TranscriptFebruary 11, 2026 | seekingalpha.comBiotricity Delivers Strong Q3 Fiscal 2026 Performance, Growing Revenue Momentum and Expanding EBITDAFebruary 11, 2026 | globenewswire.comBiotricity to Announce Continued Growth in Fiscal 2026 Third Quarter Financial Results and Business Update Call on February 11thFebruary 5, 2026 | globenewswire.comSee More Headlines BTCY Stock Analysis - Frequently Asked Questions How have BTCY shares performed this year? Biotricity's stock was trading at $0.30 at the beginning of the year. Since then, BTCY stock has decreased by 34.1% and is now trading at $0.1977. How were Biotricity's earnings last quarter? Biotricity, Inc. (NASDAQ:BTCY) posted its quarterly earnings results on Wednesday, February, 11th. The company reported ($0.04) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.08) by $0.04. The company earned $3.99 million during the quarter. Read the conference call transcript. When did Biotricity's stock split? Shares of Biotricity reverse split on Monday, July 3rd 2023.The 1-6 reverse split was announced on Monday, July 3rd 2023. The number of shares owned by shareholders was adjusted after the closing bell on Monday, July 3rd 2023. An investor that had 100 shares of stock prior to the reverse split would have 17 shares after the split. When did Biotricity IPO? Biotricity (BTCY) raised $15 million in an initial public offering (IPO) on Thursday, August 26th 2021. The company issued 5,000,000 shares at a price of $3.00 per share. H.C. Wainwright & Co. acted as the underwriter for the IPO. How do I buy shares of Biotricity? Shares of BTCY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Biotricity own? Based on aggregate information from My MarketBeat watchlists, some other companies that Biotricity investors own include NVIDIA (NVDA), Meta Platforms (META), Tesla (TSLA), Advanced Micro Devices (AMD), Broadcom (AVGO), Micron Technology (MU) and Bank of America (BAC). Company Calendar Last Earnings2/11/2026Today5/14/2026Next Earnings (Estimated)6/26/2026Fiscal Year End3/31/2027Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryMedical Equipment Current SymbolNASDAQ:BTCY Previous SymbolOTCMKTS:BTCY CIK1630113 Webwww.biotricity.com Phone(800) 590-4155FaxN/AEmployees40Year Founded2014Profitability EPS (Trailing Twelve Months)($0.16) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$14.09 million Net Margins-80.42% Pretax Margin-80.42% Return on EquityN/A Return on Assets-188.47% Debt Debt-to-Equity RatioN/A Current Ratio0.23 Quick Ratio0.10 Sales & Book Value Annual Sales$12.06 million Price / Sales0.47 Cash FlowN/A Price / Cash FlowN/A Book Value($1.30) per share Price / Book-0.15Miscellaneous Outstanding Shares28,597,000Free Float22,075,000Market Cap$5.71 million OptionableNo Data Beta1.30 Social Links Analysts Agree—These Gold Picks Outshine the RestUnlock the timeless value of gold with our exclusive 2026 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free Report This page (NASDAQ:BTCY) was last updated on 5/14/2026 by MarketBeat.com Staff. From Our PartnersTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredIran's New Leader Just Said Something That Should Terrify Every AmericanIran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...American Alternative | SponsoredPeptide Company Lands Exclusive MMA Wellness PartnershipA publicly traded peptide company just signed an exclusive partnership with a NYSE-listed MMA media platform t...The Tomorrow Investor | SponsoredCODE RED: AI Meltdown Imminent?After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...Paradigm Press | SponsoredI’m sounding the alarmMeta is cutting 10% of its workforce. Microsoft offered voluntary retirement to 7% of U.S. employees. Oracle, ...Porter & Company | SponsoredYour book is insideThe "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...Profits Run | SponsoredWhat Expenses Can Be Deducted From Capital Gains Tax This Year?Capital gains taxes can quietly erode investment returns - but the tax code offers legitimate ways to potentia...SmartAsset | SponsoredDistracted Americans set to miss out on quadrillionsTechnology expert and Washington D.C. insider Jeff Brown - who identified Bitcoin, Tesla, and Nvidia early - s...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biotricity, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Biotricity With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
